Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic Strategies

Publisher： Karger

E-ISSN： 2296-5262|37|10|584-589

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.37, Iss.10, 2014-09, pp. : 584-589

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular profiling of tumour budding implicates TGFβ‐mediated epithelial–mesenchymal transition as a therapeutic target in oral squamous cell carcinoma

By  

THE JOURNAL OF PATHOLOGY, Vol. 236, Iss. 4, 2015-08 ,pp. : 505-516

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting epithelial-mesenchymal transition: therapeutic reversal of the cancer stem cell phenotype

By Fruehauf John P   Liau Ming C  

Therapy, Vol. 8, Iss. 6, 2011-11 ,pp. : 737-740

Future Medicine

Access to resources Recommend Favorite

Cancer stem cells and epithelial–mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 7-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of epithelial-to-mesenchymal transition in renal fibrosis

By Zeisberg Michael   Kalluri Raghu  

Journal of Molecular Medicine, Vol. 82, Iss. 3, 2004-03 ,pp. : 175-181

Springer Publishing Company

Access to resources Recommend Favorite